文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

肺栓塞所致心脏骤停的治疗与结局时间趋势:全国住院数据库研究

Temporal trends in treatment and outcomes of patients with cardiac arrest due to pulmonary embolism: a nationwide inpatient database study.
PubMed 文献 · Resuscitation · 2026-06-08
一句话结论日本全国住院数据库显示,2012至2024年肺栓塞相关心脏骤停患者中溶栓使用下降、ECMO使用上升,生存率与神经功能结局均改善。

该研究回顾性分析日本全国住院数据库2012至2024年数据,纳入10390例接受心肺复苏的肺栓塞患者,中位年龄74岁,男性占44.4%。ECMO使用率18.4%,溶栓治疗使用率11.1%;总体出院生存率22.5%,出院时良好神经功能结局18.5%。溶栓使用从2012年16.0%降至2023年6.7%(p<0.001),ECMO使用从16.0%升至20.8%(p=0.015);生存率从20.9%升至24.1%(p=0.04),良好神经功能结局从17.4%升至20.6%(p=0.04)。亚组分析显示,院内获得性肺栓塞患者和接受ECMO治疗者的生存与神经功能改善尤为明显。

要点

  • 10390例肺栓塞相关心脏骤停患者中,总体出院生存率22.5%,出院时良好神经功能结局18.5%。
  • 2012至2023年溶栓使用从16.0%降至6.7%(p<0.001),ECMO使用从16.0%升至20.8%(p=0.015)。
  • 同期出院生存率从20.9%升至24.1%(p=0.04),良好神经功能结局从17.4%升至20.6%(p=0.04)。
  • 生存与神经功能改善在院内获得性肺栓塞患者及接受ECMO治疗者中尤为明显。
  • ECMO使用率18.4%,溶栓使用率11.1%,中位年龄74岁,男性44.4%。

适用人群与场景

  • 2012至2024年日本全国住院数据库中诊断为肺栓塞并接受心肺复苏的住院患者,共10390例,中位年龄74岁,男性44.4%。

研究设计与关键结果

  • 研究类型:全国住院数据库回顾性分析,纳入10390例接受心肺复苏的肺栓塞患者,数据收集时间为2012至2024年。
  • 治疗模式:ECMO使用率18.4%,溶栓治疗使用率11.1%。
  • 主要结局:出院生存率22.5%,出院时良好神经功能结局18.5%。
  • 时间趋势:溶栓使用从2012年16.0%降至2023年6.7%(p<0.001),ECMO使用从16.0%升至20.8%(p=0.015)。
  • 结局趋势:出院生存率从20.9%升至24.1%(p=0.04),良好神经功能结局从17.4%升至20.6%(p=0.04)。
  • 亚组趋势分析:生存与神经功能结局改善在院内获得性肺栓塞患者和接受ECMO治疗者中尤为明显。

证据类型、等级与局限

  • 证据类型:全国住院数据库回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究描述了肺栓塞相关心脏骤停患者中溶栓使用下降、ECMO使用上升以及生存和神经功能结局改善的时间趋势,尤其见于院内获得性肺栓塞和接受ECMO治疗的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Although cardiac arrest due to pulmonary embolism (PE) is rare, it is associated with extremely high mortality rates. We aimed to describe the patient characteristics, treatment patterns, short-term outcomes, and temporal trends in the management of PE-related cardiac arrest.

METHODS: Data collected between 2012 and 2024 from a nationwide inpatient database in Japan were retrospectively analyzed. Hospitalizations were identified using the diagnostic codes for PE and cardiopulmonary resuscitation. The co-primary outcomes were survival to hospital discharge and favorable neurological outcomes at discharge. Temporal trends in treatment patterns and outcomes were analyzed.

RESULTS: A total of 10,390 patients with PE who underwent cardiopulmonary resuscitation were identified. The median patient age was 74 years, and 44.4% of the patients were men. Extracorporeal membrane oxygenation (ECMO) was used in 18.4% of the patients, and thrombolytic therapy (TL) was used in 11.1%. Overall, 22.5% of the patients survived to hospital discharge, and 18.5% had favorable neurological outcomes at discharge. TL use decreased from 16.0% in 2012 to 6.7% in 2023 (p < 0.001), whereas ECMO use increased from 16.0% to 20.8% (p = 0.015). Survival increased from 20.9% to 24.1% (p = 0.04), and favorable neurological outcomes increased from 17.4% to 20.6% (p = 0.04). Trend subgroup analyses revealed that improvements in survival and neurological outcomes were particularly evident in both patients with hospital-acquired PE and those treated with ECMO.

CONCLUSIONS: From 2012 to 2024, TL use decreased, whereas ECMO use increased. The survival and neurological outcomes improved over time, particularly in patients with hospital-acquired PE and those who received ECMO.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Ishida K, Nishimoto Y, Ohbe H, et al. Temporal trends in treatment and outcomes of patients with cardiac arrest due to pulmonary embolism: a nationwide inpatient database study. Resuscitation. 2026. PMID: 42264174. doi:10.1016/j.resuscitation.2026.111167

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。